A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)
Condition: COVID-19 Interventions: Drug: Azeliragon; Drug: Placebo Sponsor: Salim S. Hayek Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials